menu ☰
menu ˟

[Comment] Hepatitis C beware—the end is nigh

01 Nov 2014

Chronic infection with hepatitis C virus (HCV) is a global epidemic that affects more than 180 million individuals worldwide. Because of low rates of treatment and an ageing population, the proportion of people infected with HCV in the USA who will develop established cirrhosis is projected to increase from 15% to over 45%. This increase is expected to result in a trebling of the rates of HCV-related liver failure and hepatocellular carcinoma by 2030. The benefits of current interferon-based therapies are limited by poor tolerability and efficacy.

Click here to view the full article which appeared in The Lancet